Pulmatrix(PULM) - 2024 Q1 - Quarterly Results

First Quarter 2024 and Recent Program and Corporate Highlights Ted Raad, Chief Executive Officer of Pulmatrix, commented, "Our focus in the first quarter has been to continue our cost saving measures including the wind down of the Phase 2b study for PUR1900 and on strategic alternatives that leverage the potential of PUR3100, iSPERSE™ technology and our extended cash resources." Exhibit 99.1 Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update PUR3100 $16.3 million in cash ...